2022
DOI: 10.3390/bios12110931
|View full text |Cite
|
Sign up to set email alerts
|

Prostate-Specific Antigen Monitoring Using Nano Zinc(II) Metal–Organic Framework-Based Optical Biosensor

Abstract: Background: The prostate-specific antigen (PSA) is an important cancer biomarker that is commonly utilized in the diagnosis of prostate cancer. The development of a PSA determination technique that is rapid, simple, and inexpensive, in addition to highly accurate, sensitive, and selective, remains a formidable obstacle. Methods: In this study, we developed a practical biosensor based on Zn(II) metal–organic framework nanoparticles (Zn-MOFs-NPs). Many spectroscopic and microanalytical tools are used to determin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 71 publications
0
2
0
Order By: Relevance
“…The prostate-specific antigen (PSA), a glycoprotein of 237 amino acids that are released by the prostate gland, is the most important and common biomarker for prostate cancer. A biosensor based on Zn(II) metal–organic framework NPs can detect the PSA at a detection limit of 0.145 fg/mL where the PSA concentration > 10 ng/mL is considered a threat for suspected prostate cancers [ 206 ]. The antibodies against PSA and prostate-specific membrane antigen (PSMA) were decorated on Fe 3 O 4 nanoparticles which are loaded onto graphene oxide (GO) nano-sheets for microfluidic immunoarray based on electrochemical reaction [ 207 ].…”
Section: Nanotechnology For the Detection Of Cancer Biomarkersmentioning
confidence: 99%
“…The prostate-specific antigen (PSA), a glycoprotein of 237 amino acids that are released by the prostate gland, is the most important and common biomarker for prostate cancer. A biosensor based on Zn(II) metal–organic framework NPs can detect the PSA at a detection limit of 0.145 fg/mL where the PSA concentration > 10 ng/mL is considered a threat for suspected prostate cancers [ 206 ]. The antibodies against PSA and prostate-specific membrane antigen (PSMA) were decorated on Fe 3 O 4 nanoparticles which are loaded onto graphene oxide (GO) nano-sheets for microfluidic immunoarray based on electrochemical reaction [ 207 ].…”
Section: Nanotechnology For the Detection Of Cancer Biomarkersmentioning
confidence: 99%
“…This pathology is one of the most common cancer types suffered by men, with an increasing incidence and mortality rate worldwide [ 20 , 21 ]. The etiology of PC has not been completely elucidated, although several factors could be associated with it, including aging, family history, and genetic mutations [ 20 , 22 , 23 ].…”
Section: Introductionmentioning
confidence: 99%